Kathryn Hester, Ph.D., Becomes Dunlap Codding’s Risk Manager
Kathryn Hester, Ph.D., has been named Dunlap Codding’s Risk Manager. As Risk Manager for the firm, she will confer with the firm’s Board of Directors and will be responsible for identifying areas of risk for the firm and its clients, establishing policies and procedures to guard against those risks, and monitoring compliance with the policies and procedures. Dunlap Codding’s Managing Shareholder Nick Rouse said, “Kathryn is the perfect person to serve as our Risk Manager in light of her extreme dedication, attention to detail, and her client-driven perspective.”
Dr. Hester is a patent agent registered to practice before the United States Patent and Trademark Office. She focuses on patent prosecution and provides strategic and tactical patent counseling to clients that include start-up biotechnology companies as well as universities and large pharmaceutical and manufacturing companies. Kathryn’s technological focus includes all areas of biotechnology, including molecular biology, cell biology, glycobiology, biochemistry, developmental biology, immunology, microbiology, virology, and genetics; pharmaceutical compositions; molecular diagnostics and techniques; medical devices and equipment; and the chemical and mechanical arts. She received her Ph.D. from the University of Oklahoma, with honors, in Biochemistry & Molecular Biology, and her B.S. from Southern Nazarene University, summa cum laude, in Chemistry.